Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Wiens · SciRah

Researcher profile · Semantic Scholar

B. Wiens

Share profile

B. Wiens — researcher profile on SciRah

h-index: 26
Works: 72
Citations: 6,410

Most-cited papers

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
D. Siegal, J. Curnutte, S. Connolly, Gen-Min Lu +9 more
2015New England Journal of Medicine1,010 citations Open access
Semantic Scholar
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
N. Galie', H. Olschewski, R. Oudiz, F. Torres +10 more
2008Circulation1,004 citations Open access
Semantic Scholar
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
S. Friedman, V. Ratziu, S. Harrison, M. Abdelmalek +19 more
2018Hepatology601 citations Open access
Semantic Scholar
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.
Alan Werzberger, Barbara Mensch, B. Kuter, L. Brown +9 more
1992New England Journal of Medicine521 citations Open access
Semantic Scholar
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.
C. Vogel, M. Wojtukiewicz, R. Carroll, S. Tjulandin +4 more
2005Journal of Clinical Oncology506 citations Open access
Semantic Scholar
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
A. T. Cohen, R. Harrington, S. Goldhaber, Russell D. Hull +4 more
2016New England Journal of Medicine412 citations Open access
Semantic Scholar
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
M. Weber, H. Black, G. Bakris, H. Krum +6 more
2009The Lancet322 citations
Semantic Scholar
Choosing an equivalence limit for noninferiority or equivalence studies.
B. Wiens
2002Controlled Clinical Trials164 citations
Semantic Scholar
A fixed sequence Bonferroni procedure for testing multiple endpoints
B. Wiens
2003161 citations
Semantic Scholar
Effects of losartan on a background of hydrochlorothiazide in patients with hypertension.
B. Soffer, J. Wright, J. Pratt, B. Wiens +2 more
1995HYPERTENSION150 citations
Semantic Scholar
General Multistage Gatekeeping Procedures
A. Dmitrienko, Ajit C. Tamhane, B. Wiens
2008Biometrical journal. Biometrische Zeitschrift134 citations
Semantic Scholar
The Fallback Procedure for Evaluating a Single Family of Hypotheses
B. Wiens, A. Dmitrienko
2005Journal of Biopharmaceutical Statistics134 citations
Semantic Scholar
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
M. Metra, Eric J. Eichhorn, W. Abraham, J. Linseman +17 more
2009European Heart Journal126 citations Open access
Semantic Scholar
Tree‐structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives
A. Dmitrienko, B. Wiens, A. Tamhane, Xin Wang
2007Statistics in Medicine116 citations
Semantic Scholar
Duration of protection from clinical hepatitis A disease after vaccination with VAQTA®
B. Wiens, N. Bohidar, J. Pigeon, J. Egan +4 more
1996Journal of Medical Virology102 citations Open access
Semantic Scholar
Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Study
Henry R. Black, G. Bakris, Michael A. Weber, Robert G. Weiss +8 more
2007The Journal of Clinical Hypertension99 citations Open access
Semantic Scholar
When Log-Normal and Gamma Models Give Different Results: A Case Study
B. Wiens
199997 citations
Semantic Scholar
Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview.
D. Nalin, B. Kuter, L. Brown, C. Patterson +13 more
1993Journal of Hepatology85 citations
Semantic Scholar
The role of intention to treat in analysis of noninferiority studies
B. Wiens, William Y Zhao
2007Clinical Trials64 citations
Semantic Scholar
ABX-EGF monotherapy in patients (pts) with metastatic colorectal cancer (mCRC): An updated analysis
J. Hecht, A. Patnaik, I. Malik, A. Venook +6 more
200463 citations
Semantic Scholar
Design and Analysis of Non-Inferiority Trials
Mark Rothmann, B. Wiens, I. Chan
202061 citations
Semantic Scholar
Multiple testing methodology
A. Dmitrienko, F. Bretz, P. Westfall, J. Troendle +3 more
200948 citations
Semantic Scholar
ABX-EGF monotherapy in patients (pts) with metastatic colorectal cancer (mCRC): An updated analysis.
J. Hecht, A. Patnaik, I. Malik, A. Venook +6 more
2004Journal of Clinical Oncology42 citations
Semantic Scholar
Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults.
E. Walter, R. Hornick, G. Poland, Richard M. Tucker +9 more
1999Vaccine37 citations
Semantic Scholar
A note on tree gatekeeping procedures in clinical trials
A. Dmitrienko, Ajit C. Tamhane, Lingyun Liu, B. Wiens
2008Statistics in Medicine33 citations
Semantic Scholar
Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy
A. Cowley, B. Wiens, Robert Segal, M. Rich +3 more
2004Quality of Life Research32 citations
Semantic Scholar
Cenicriviroc placebo for the treatment of non-alcoholic steatohepatitis with liver fibrosis: Results from the Year 1 primary analysis of the Phase 2b CENTAUR study
A. Sanyal, F. Tacke, L. Fischer, Jeffrey D. Vest +19 more
201626 citations
Semantic Scholar
Antibody responses of healthy infants to a recombinant hepatitis B vaccine administered at two, four, and twelve or fifteen months of age.
H. Keyserling, David J. West, T. Hesley, Caminade Bosley +2 more
1994Jornal de Pediatria26 citations
Semantic Scholar
Design and analysis of three treatment equivalence trials.
B. Wiens, Boris Iglewicz
2000Controlled Clinical Trials24 citations
Semantic Scholar
Fallback Tests in Dose-Response Clinical Trials
A. Dmitrienko, B. Wiens, P. Westfall
2006Journal of Biopharmaceutical Statistics23 citations
Semantic Scholar
On Selecting a Multiple Comparison Procedure for Analysis of a Clinical Trial: Fallback, Fixed Sequence, and Related Procedures
B. Wiens, A. Dmitrienko
201019 citations
Semantic Scholar
Testing for Interaction in Studies of Noninferiority
B. Wiens, J. Heyse
2003Journal of Biopharmaceutical Statistics19 citations
Semantic Scholar
Selection of Hypothesis Weights and Ordering When Testing Multiple Hypotheses in Clinical Trials
B. Wiens, A. Dmitrienko, Olga Marchenko
2013Journal of Biopharmaceutical Statistics18 citations
Semantic Scholar
On testing equivalence of three populations.
B. Wiens, Boris Iglewicz
1999Journal of Biopharmaceutical Statistics18 citations
Semantic Scholar
Something for Nothing in Noninferiority/Superiority Testing: A Caution
B. Wiens
200117 citations
Semantic Scholar
Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial.
Alan Werzberger, B. Kuter, D. Shouval, Barbara Mensch +7 more
1993Journal of Hepatology16 citations
Semantic Scholar
Statistical Models for Predicting the Duration of Vaccine-Induced Protection
J. Pigeon, N. Bohidar, Zhongxin Zhang, B. Wiens
199911 citations
Semantic Scholar
Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials
B. Wiens
2018Journal of Biopharmaceutical Statistics10 citations
Semantic Scholar
Missing Data in Noninferiority Trials
B. Wiens, G. Rosenkranz
201310 citations
Semantic Scholar
Randomization as a basis for inference in noninferiority trials
B. Wiens
2006Pharmaceutical statistics8 citations
Semantic Scholar
176 Andexanet Alfa: An Investigational Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers.
Florie A. Mar, M. Crowther, A. Gold, Gen-Min Lu +7 more
2016Neurosurgery6 citations
Semantic Scholar
Testing Noninferiority of Response Rates for Regulatory Filings Using Transformations
B. Wiens, Boris Iglewicz
20016 citations
Semantic Scholar
The Role of Multiple Imputation in Noninferiority Trials for Binary Outcomes
I. Lipkovich, B. Wiens
20184 citations
Semantic Scholar
Recent Statistical Contributions to Medical Device Development
B. Wiens, Theodore C. Lystig, S. Berry
2014Therapeutic Innovation and Regulatory Science4 citations
Semantic Scholar
Multiple Testing Procedures in Two Pivotal Clinical Trials for Approval of a New Pharmaceutical Product
B. Wiens
2011Journal of Biopharmaceutical Statistics4 citations
Semantic Scholar
Erratum: Tree structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives (Statistics in Medicine (2007) vol. 26 (2465-2478))
A. Dmitrienko, B. Wiens, A. Tamhane, Xin Wang
20084 citations Open access
Semantic Scholar
Hepatic fibrosis is associated with histological activity in nonalcoholic steatohepatitis: an analysis from a large database of screening biopsies in the CENTAUR trial
V. Ratziu, V. Wong, N. Lanthier, J. Boursier +15 more
20173 citations
Semantic Scholar
The Impact of Major Events on Ongoing Noninferiority Trials, With Application to COVID-19
B. Wiens, I. Lipkovich
2020Statistics in Biopharmaceutical Research2 citations Open access
Semantic Scholar
Abstract 212: Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers
M. Crowther, A. Gold, Gen-Min Lu, J. Leeds +6 more
20162 citations
Semantic Scholar
vte Prevention in Acutely Ill Medical Patients with Extended Duration Betrixaban - A Multicenter, Randomized, Active-controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin : ca02
C. Gibson, R. Harrington, S. Goldhaber, Adrian F. Hernandez +4 more
20162 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Dmitrienko×8
Invite
A. Dmitrienko — researcher profile on SciRah
A. Gold×5
Invite
A. Gold — researcher profile on SciRah
L. Brown×5
Invite
L. Brown — researcher profile on SciRah
B. Kuter×4
Invite
B. Kuter — researcher profile on SciRah

×4

Invite

D. Nalin — researcher profile on SciRah

Invite

J. Curnutte — researcher profile on SciRah

Invite

S. Connolly — researcher profile on SciRah

Invite

Gen-Min Lu — researcher profile on SciRah

Invite

V. Mathur — researcher profile on SciRah

Invite

J. Castillo — researcher profile on SciRah

Invite

J. Leeds — researcher profile on SciRah

Invite

M. Crowther — researcher profile on SciRah